Newsfile Corp
04 Oct 2026, 21:18 UTC · 5h ago
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX
Impact · against what's priced in
The announcements regarding lead plaintiff deadlines for existing class actions are non-material for DOCS and CELH as their current valuations already incorporate these legal risks. For ARDX, the news confirms ongoing litigation regarding reimbursement barriers for XPHOZAH and IBSRELA, posing a negative but likely already recognized headwind.
- CELH+0.00
Already priced in
- The price assumes
The immediate legal and reputational risks from the Texas AG investigation and wrongful death lawsuits





